|
⚲
|
| China Aoxing Pharmaceutical Company Inc | |
|---|---|
| Firm | |
| Fund # | |
| CIK # | 0001060426 |
| Sale | 2009-08-06 ($5.0 M Offered, $5.0 M Sold) |
| Fund | |
| Phone | 6463671747 |
| Address | 15 Exchange Place, Suite 500 Jersey City, 07302 |
| Source | [EDGAR] |
| Fund AUM and Sold ($M) |
|---|
| Fund Details | |
|---|---|
| Director | |
| Custodian | |
| Auditor | |
| Marketer | |
| Broker | |
| Jurisdiction |
| Directors | 2011 - 2025 |
|---|---|
| Zhenjiang Yue | |
| John Oshea | |
| Jun Min | |
| Howard Sterling | |
| Guozhu Xu | |
| Hui Shao |
| Comparable Firms | State | AUM ($B) |
|---|---|---|
|
Osherova Maria
✚
|
0.0 | |
|
Oskoui Stephen D.
✚
|
0.0 | |
|
Osmond John
✚
|
0.0 | |
|
Ota Ken
✚
|
0.0 | |
|
NL Life Sciences BV
✚
|
0.0 | |
|
NMSIC Focused LLC
✚
|
0.0 | |
|
Noble Opportunity Fund I, L.P.
✚
|
0.0 | |
|
Node-Langlois Pascal
✚
|
0.0 | |
|
Nodiff Eric W
✚
|
0.0 | |
|
Orobono John Michael Jr.
✚
|
0.0 |